Profil
Alain Bernard is currently the Chief Technology Officer at VectivBio Holding AG since 2019.
Prior to this, he worked as the Head-Global Biotech Process Development at R-Pharm JSC from 2017 to 2019, Vice President-Biopharmaceutical Process Sciences at UCB SA from 2006 to 2016, and Director-Biotech Process Development at Merck Serono SA from 2002 to 2006.
Dr. Bernard holds a doctorate degree from the Massachusetts Institute of Technology.
Ehemalige bekannte Positionen von Alain Bernard
| Unternehmen | Position | Ende |
|---|---|---|
R-Pharm JSC
 R-Pharm JSC BiotechnologyHealth Technology R-Pharm JSC engages in the research, development, and manufacture of medicines. It also distributes laboratory supplies and medical equipment. The company was founded by Alexey Yevgenyevich Repik on August 17, 2001 and is headquartered in Moscow, Russia. | Corporate Officer/Principal | 01.07.2019 |
| UCB | Corporate Officer/Principal | 01.01.2016 |
Merck Serono SA
 Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Corporate Officer/Principal | 01.11.2006 |
| VECTIVBIO HOLDING AG | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Alain Bernard
| Massachusetts Institute of Technology | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| UCB | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Merck Serono SA
Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Health Technology |
R-Pharm JSC
R-Pharm JSC BiotechnologyHealth Technology R-Pharm JSC engages in the research, development, and manufacture of medicines. It also distributes laboratory supplies and medical equipment. The company was founded by Alexey Yevgenyevich Repik on August 17, 2001 and is headquartered in Moscow, Russia. | Health Technology |
VectivBio Holding AG
 VectivBio Holding AG Pharmaceuticals: MajorHealth Technology VectivBio Holding AG is a clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of treatments for severe rare conditions with significant unmet medical need. It operates through Switzerland, Canada, and the United States geographical segment. The company was founded by Luca Santarelli on May 22, 2019 and is headquartered in Basel, Switzerland. | Health Technology |
